Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Barrios Vivencio  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 427-439

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination Therapy: Post Hoc Analysis of Data from a Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Mourad Jean-Jacques   >  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 419-425

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of a Fixed-Dose Combination of Metoprolol Extended Release/Amlodipine in Patients with Mild-to-Moderate Hypertension: A Randomized, Parallel-Group, Multicentre Comparison with Losartan plus Amlodipine

By Pareek Anil  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 123-131

Adis International

Access to resources Recommend Favorite

Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension: The TRINITY Randomized, Double-Blind, 12-Week, Parallel-Group Study

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 233-243

Adis International

Access to resources Recommend Favorite